CompanyHealthHardware
Kaleido
Kaleido is a small, discreet, customizable insulin patch pump built by Dutch medtech company ViCentra to make living with diabetes less of a burden. Designed to look and feel like a lifestyle product rather than a clinical device, Kaleido pairs with Diabeloop's self-learning algorithm and the Dexcom CGM to enable hybrid closed-loop, app-controlled insulin delivery. With more than 3,500 users in Europe and an $85M+ Series D raised in 2025, the company is scaling manufacturing of its next-generation Kaleido 2 and preparing for entry into the United States.
2013Founded
UtrechtHQ
$85M (≈€72.4M), later extended to ~$98MSeries D
insulin pumppatch pumpdiabetesdiabetes caremedical devicesinsulin delivery
